| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.60e-06 | 18 | 128 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 DNAH3 APPBP2 MYO1D DNAH10 TCP1 DYNC2H1 HSPH1 DHX57 XRCC5 DNAH7 RALBP1 MACF1 DHX29 ABCG5 | 9.37e-06 | 614 | 128 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.93e-05 | 28 | 128 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | pyruvate kinase activity | 4.08e-05 | 2 | 128 | 2 | GO:0004743 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 8.68e-05 | 70 | 128 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 9.03e-05 | 37 | 128 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 1.11e-04 | 15 | 128 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.13e-04 | 118 | 128 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | preprotein binding | 1.22e-04 | 3 | 128 | 2 | GO:0070678 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSPD1 DNAH3 DNAH10 TCP1 DYNC2H1 DHX57 XRCC5 DNAH7 MACF1 DHX29 ABCG5 | 1.29e-04 | 441 | 128 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSPD1 DNAH3 DNAH10 TCP1 DYNC2H1 LRRK2 DHX57 XRCC5 DNAH7 OPA1 GNA13 MACF1 REM2 DHX29 ABCG5 | 1.34e-04 | 775 | 128 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors | 1.64e-04 | 17 | 128 | 3 | GO:0016661 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 1.64e-04 | 17 | 128 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 2.52e-04 | 48 | 128 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSPD1 DNAH3 DNAH10 TCP1 DYNC2H1 LRRK2 DHX57 XRCC5 DNAH7 OPA1 GNA13 MACF1 REM2 DHX29 ABCG5 | 3.15e-04 | 839 | 128 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSPD1 DNAH3 DNAH10 TCP1 DYNC2H1 LRRK2 DHX57 XRCC5 DNAH7 OPA1 GNA13 MACF1 REM2 DHX29 ABCG5 | 3.19e-04 | 840 | 128 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSPD1 DNAH3 DNAH10 TCP1 DYNC2H1 LRRK2 DHX57 XRCC5 DNAH7 OPA1 GNA13 MACF1 REM2 DHX29 ABCG5 | 3.19e-04 | 840 | 128 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 3.62e-04 | 22 | 128 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | TET2 CHDH XDH SUCLG2 PDIA4 ALDH1L2 HSD17B13 TXNRD3 MTARC2 ALDH1A1 HADH ALDH2 HSD11B1 HSD17B4 | 4.05e-04 | 766 | 128 | 14 | GO:0016491 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 4.57e-04 | 56 | 128 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 4.72e-04 | 24 | 128 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPM6 CACNA1D RASA3 SLC2A7 TMEM63B SLCO1B3 RYR3 CEACAM1 SEC61A2 SLC13A1 TOMM40L RALBP1 SLC25A1 SCN5A LRP5 TOMM40 ABCG5 CACNA2D3 | 5.31e-04 | 1180 | 128 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 5.34e-04 | 25 | 128 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | porin activity | 6.01e-04 | 6 | 128 | 2 | GO:0015288 | |
| GeneOntologyMolecularFunction | molybdenum ion binding | 6.01e-04 | 6 | 128 | 2 | GO:0030151 | |
| GeneOntologyMolecularFunction | molybdopterin cofactor binding | 6.01e-04 | 6 | 128 | 2 | GO:0043546 | |
| GeneOntologyMolecularFunction | 3-hydroxyacyl-CoA dehydrogenase activity | 6.01e-04 | 6 | 128 | 2 | GO:0003857 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 6.72e-04 | 27 | 128 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 7.50e-04 | 28 | 128 | 3 | GO:0008320 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.22e-03 | 33 | 128 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | NAD binding | 1.25e-03 | 73 | 128 | 4 | GO:0051287 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 1.33e-03 | 34 | 128 | 3 | GO:0022884 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 1.43e-03 | 9 | 128 | 2 | GO:0043878 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.46e-03 | 129 | 128 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | transporter activity | TRPM6 CACNA1D RASA3 SLC2A7 TMEM63B SLCO1B3 RYR3 CEACAM1 SEC61A2 SLC13A1 TOMM40L RALBP1 SLC25A1 SCN5A LRP5 TOMM40 ABCG5 CACNA2D3 | 1.46e-03 | 1289 | 128 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.68e-03 | 343 | 128 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.97e-03 | 138 | 128 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.99e-03 | 39 | 128 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.14e-03 | 40 | 128 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | nitrite reductase activity | 2.16e-03 | 11 | 128 | 2 | GO:0098809 | |
| GeneOntologyMolecularFunction | protein transporter activity | 2.46e-03 | 42 | 128 | 3 | GO:0140318 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.91e-03 | 151 | 128 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 3.53e-03 | 97 | 128 | 4 | GO:0008081 | |
| GeneOntologyMolecularFunction | potassium ion binding | 3.53e-03 | 14 | 128 | 2 | GO:0030955 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of a nerve | 1.67e-06 | 15 | 125 | 4 | GO:0048755 | |
| GeneOntologyCellularComponent | microtubule | CYLD DNAH3 APPBP2 DNAH10 MAP1B TCP1 DYNC2H1 HSPH1 TRIP10 DNAH7 OPA1 RASSF5 MACF1 | 2.64e-05 | 533 | 129 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | inner dynein arm | 2.67e-05 | 10 | 129 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | pyruvate kinase complex | 3.78e-05 | 2 | 129 | 2 | GO:1902912 | |
| GeneOntologyCellularComponent | cilium | HSPD1 CYLD GPI DNAH3 DRD2 PDE6A DNAH10 MAP1B PDE6B DYNC2H1 USH1C DNAH7 CEACAM1 FANK1 PPP3CC PKM CFAP69 | 3.83e-05 | 898 | 129 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | cell projection membrane | TRPM6 GPI CACNA1D DRD2 PDE6A MYO1D FGD2 PDE6B CEACAM1 GNA13 MACF1 | 7.58e-05 | 431 | 129 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | supramolecular fiber | CYLD CACNA1D DNAH3 APPBP2 DNAH10 MAP1B TCP1 DYNC2H1 INPP5D HSPH1 CMYA5 NEB TRIP10 DNAH7 OPA1 RYR3 RASSF5 SCN5A MACF1 | 1.13e-04 | 1179 | 129 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.17e-04 | 238 | 129 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | supramolecular polymer | CYLD CACNA1D DNAH3 APPBP2 DNAH10 MAP1B TCP1 DYNC2H1 INPP5D HSPH1 CMYA5 NEB TRIP10 DNAH7 OPA1 RYR3 RASSF5 SCN5A MACF1 | 1.24e-04 | 1187 | 129 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | dynein complex | 3.45e-04 | 54 | 129 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | ciliary membrane | 3.55e-04 | 98 | 129 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.78e-04 | 25 | 129 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | microtubule associated complex | 4.96e-04 | 161 | 129 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | microvillus | 1.00e-03 | 123 | 129 | 5 | GO:0005902 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CYLD DNAH3 APPBP2 DNAH10 MAP1B TCP1 DYNC2H1 INPP5D HSPH1 TRIP10 DNAH7 OPA1 RASSF5 MACF1 | 1.33e-03 | 899 | 129 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | non-motile cilium | 1.38e-03 | 196 | 129 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | motile cilium | 1.64e-03 | 355 | 129 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.79e-03 | 360 | 129 | 8 | GO:0099568 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.13e-06 | 14 | 130 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.13e-06 | 14 | 130 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.13e-06 | 14 | 130 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.13e-06 | 14 | 130 | 4 | PF08393 | |
| Domain | MT | 2.13e-06 | 14 | 130 | 4 | PF12777 | |
| Domain | AAA_8 | 2.13e-06 | 14 | 130 | 4 | PF12780 | |
| Domain | DHC_fam | 2.88e-06 | 15 | 130 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.88e-06 | 15 | 130 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.88e-06 | 15 | 130 | 4 | IPR004273 | |
| Domain | Pyrv_Knase-like_insert_dom | 3.26e-06 | 5 | 130 | 3 | IPR011037 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 3.40.1380.20 | |
| Domain | PYRUVATE_KINASE | 4.81e-05 | 2 | 130 | 2 | PS00110 | |
| Domain | Pyrv_Knase_insert_dom | 4.81e-05 | 2 | 130 | 2 | IPR015806 | |
| Domain | PK | 4.81e-05 | 2 | 130 | 2 | PF00224 | |
| Domain | PK_C | 4.81e-05 | 2 | 130 | 2 | PF02887 | |
| Domain | - | 4.81e-05 | 2 | 130 | 2 | 2.40.33.10 | |
| Domain | Pyrv_Knase_AS | 4.81e-05 | 2 | 130 | 2 | IPR018209 | |
| Domain | Pyrv_Knase_brl | 4.81e-05 | 2 | 130 | 2 | IPR015793 | |
| Domain | Pyrv_Knase_a/b | 4.81e-05 | 2 | 130 | 2 | IPR015794 | |
| Domain | Pyrv_Knase_C | 4.81e-05 | 2 | 130 | 2 | IPR015795 | |
| Domain | ATPase_dyneun-rel_AAA | 1.13e-04 | 14 | 130 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.13e-04 | 14 | 130 | 3 | PF07728 | |
| Domain | Pyr_Knase | 1.44e-04 | 3 | 130 | 2 | IPR001697 | |
| Domain | Pyrv/PenolPyrv_Kinase-like_dom | 1.44e-04 | 3 | 130 | 2 | IPR015813 | |
| Domain | - | 1.44e-04 | 3 | 130 | 2 | 3.20.20.60 | |
| Domain | RNA3'P_cycl/enolpyr_Trfase_a/b | 1.44e-04 | 3 | 130 | 2 | IPR013792 | |
| Domain | Ald_DH_CS_GLU | 1.73e-04 | 16 | 130 | 3 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 2.09e-04 | 17 | 130 | 3 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 2.49e-04 | 18 | 130 | 3 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 2.49e-04 | 18 | 130 | 3 | PS00687 | |
| Domain | - | 2.94e-04 | 19 | 130 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 2.94e-04 | 19 | 130 | 3 | PF00171 | |
| Domain | PDEase | 2.94e-04 | 19 | 130 | 3 | IPR023088 | |
| Domain | Ald_DH_C | 2.94e-04 | 19 | 130 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 2.94e-04 | 19 | 130 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 2.94e-04 | 19 | 130 | 3 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 2.94e-04 | 19 | 130 | 3 | IPR015590 | |
| Domain | - | 2.94e-04 | 19 | 130 | 3 | 3.40.309.10 | |
| Domain | PDEase_I | 4.00e-04 | 21 | 130 | 3 | PF00233 | |
| Domain | PDEASE_I | 4.00e-04 | 21 | 130 | 3 | PS00126 | |
| Domain | PDEase_CS | 4.00e-04 | 21 | 130 | 3 | IPR023174 | |
| Domain | - | 4.61e-04 | 22 | 130 | 3 | 1.10.1300.10 | |
| Domain | - | 4.74e-04 | 5 | 130 | 2 | 2.40.290.10 | |
| Domain | Porin_dom | 4.74e-04 | 5 | 130 | 2 | IPR023614 | |
| Domain | - | 4.74e-04 | 5 | 130 | 2 | 2.40.160.10 | |
| Domain | Porin_Euk/Tom40 | 4.74e-04 | 5 | 130 | 2 | IPR027246 | |
| Domain | Porin_3 | 4.74e-04 | 5 | 130 | 2 | PF01459 | |
| Domain | SPOC-like_C_dom | 4.74e-04 | 5 | 130 | 2 | IPR016194 | |
| Domain | Porin_Euk | 4.74e-04 | 5 | 130 | 2 | IPR001925 | |
| Domain | PDEase_catalytic_dom | 5.27e-04 | 23 | 130 | 3 | IPR002073 | |
| Domain | HD/PDEase_dom | 5.99e-04 | 24 | 130 | 3 | IPR003607 | |
| Domain | HDc | 5.99e-04 | 24 | 130 | 3 | SM00471 | |
| Domain | GAF | 9.87e-04 | 7 | 130 | 2 | PF01590 | |
| Domain | DHC_N1 | 1.31e-03 | 8 | 130 | 2 | PF08385 | |
| Domain | GAF | 1.31e-03 | 8 | 130 | 2 | IPR003018 | |
| Domain | GAF | 1.31e-03 | 8 | 130 | 2 | SM00065 | |
| Domain | Dynein_heavy_dom-1 | 1.31e-03 | 8 | 130 | 2 | IPR013594 | |
| Domain | Chaprnin_Cpn60 | 1.68e-03 | 9 | 130 | 2 | IPR001844 | |
| Domain | VHS | 1.68e-03 | 9 | 130 | 2 | PS50179 | |
| Domain | - | 1.68e-03 | 9 | 130 | 2 | 3.30.450.40 | |
| Domain | VHS | 1.68e-03 | 9 | 130 | 2 | PF00790 | |
| Domain | GAF_dom-like | 1.68e-03 | 9 | 130 | 2 | IPR029016 | |
| Domain | VHS | 1.68e-03 | 9 | 130 | 2 | SM00288 | |
| Domain | VHS_dom | 1.68e-03 | 9 | 130 | 2 | IPR002014 | |
| Domain | - | 1.77e-03 | 74 | 130 | 4 | 3.40.50.410 | |
| Domain | UBA | 1.99e-03 | 36 | 130 | 3 | PF00627 | |
| Domain | Glyco_transf_8 | 2.09e-03 | 10 | 130 | 2 | PF01501 | |
| Domain | Glyco_trans_8 | 2.09e-03 | 10 | 130 | 2 | IPR002495 | |
| Domain | AAA | 3.36e-03 | 144 | 130 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 3.36e-03 | 144 | 130 | 5 | IPR003593 | |
| Domain | UBA | 3.54e-03 | 44 | 130 | 3 | IPR015940 | |
| Domain | GROEL-like_equatorial | 4.14e-03 | 14 | 130 | 2 | IPR027413 | |
| Domain | ATP_GRASP | 4.14e-03 | 14 | 130 | 2 | PS50975 | |
| Domain | ATP-grasp | 4.14e-03 | 14 | 130 | 2 | IPR011761 | |
| Domain | - | 4.14e-03 | 14 | 130 | 2 | 1.10.560.10 | |
| Domain | UBA | 4.27e-03 | 47 | 130 | 3 | PS50030 | |
| Domain | GroEL-like_apical_dom | 4.76e-03 | 15 | 130 | 2 | IPR027409 | |
| Domain | Cpn60/TCP-1 | 4.76e-03 | 15 | 130 | 2 | IPR002423 | |
| Domain | Cpn60_TCP1 | 4.76e-03 | 15 | 130 | 2 | PF00118 | |
| Domain | - | 4.76e-03 | 15 | 130 | 2 | 3.50.7.10 | |
| Domain | - | 4.76e-03 | 15 | 130 | 2 | 3.30.1490.20 | |
| Domain | VWF_A | 5.07e-03 | 99 | 130 | 4 | IPR002035 | |
| Domain | ADH_SHORT | 5.99e-03 | 53 | 130 | 3 | PS00061 | |
| Domain | Quinoprotein_ADH-like_supfam | 5.99e-03 | 53 | 130 | 3 | IPR011047 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 6.11e-03 | 17 | 130 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 6.11e-03 | 17 | 130 | 2 | PS51059 | |
| Domain | PARP | 6.11e-03 | 17 | 130 | 2 | PF00644 | |
| Domain | DUF1605 | 6.11e-03 | 17 | 130 | 2 | IPR011709 | |
| Domain | - | 6.11e-03 | 17 | 130 | 2 | 3.90.228.10 | |
| Domain | OB_NTP_bind | 6.11e-03 | 17 | 130 | 2 | PF07717 | |
| Domain | adh_short | 6.64e-03 | 55 | 130 | 3 | PF00106 | |
| Domain | ATP_grasp_subdomain_1 | 6.84e-03 | 18 | 130 | 2 | IPR013815 | |
| Domain | - | 6.84e-03 | 18 | 130 | 2 | 3.30.470.20 | |
| Domain | HA2 | 6.84e-03 | 18 | 130 | 2 | SM00847 | |
| Domain | HA2 | 6.84e-03 | 18 | 130 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 6.84e-03 | 18 | 130 | 2 | IPR007502 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 3.97e-07 | 91 | 106 | 8 | M48079 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 HSPD1 GPI EPRS1 SLK MYO1D DNAH10 TCP1 DYNC2H1 CHAF1A HSPH1 UBR4 FASTKD2 CMYA5 XRCC5 OPA1 PDIA4 PBRM1 PIM1 PKM TOMM40 ALDH2 HSD17B4 PUM1 PC SPEN DHX29 CAP1 ZC3HAV1 RAD21 KPNA2 RAD23B | 1.94e-16 | 1425 | 131 | 32 | 30948266 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | HSPD1 GPI SLK PDE8A MYO1D TCP1 DYNC2H1 LRRK2 PM20D1 NEB TRIP10 CEMIP2 VPS13D ASAH1 SLC25A1 PKLR PKM ALCAM ALDH1A1 ALDH2 SPEN CAP1 | 3.57e-11 | 1016 | 131 | 22 | 19056867 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GPI SLK MAP1B TCP1 HSPH1 UBR4 XRCC5 SUCLG2 TRIP10 OPA1 PDIA4 ASAH1 SLC25A1 RTCA PKM PYGL ALCAM HSD17B4 PC DHX29 GOLGB1 ZC3HAV1 RAD21 KPNA2 RAD23B | 5.11e-11 | 1367 | 131 | 25 | 32687490 |
| Pubmed | HSPD1 EPRS1 PDE6A MYO1D MAP1B CHAF1A HSPH1 UBR4 LLPH DHX57 NEB XRCC5 PDIA4 SEC61A2 SLC25A1 GNA13 PKM MACF1 ALCAM ALDH1A1 ALDH2 HSD17B4 SPEN CFAP69 GOLGB1 | 1.57e-10 | 1442 | 131 | 25 | 35575683 | |
| Pubmed | HSPD1 EPRS1 MYO1D TCP1 HSPH1 DHX57 XRCC5 SUCLG2 PDIA4 SLC25A1 RTCA PKM HSD17B4 ZC3HAV1 KPNA2 | 3.25e-10 | 469 | 131 | 15 | 37314180 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HSPD1 EPRS1 TCP1 CHAF1A HSPH1 UBR4 LLPH FASTKD2 XRCC5 SUCLG2 OPA1 PBRM1 SLC25A1 PKLR PKM PYGL TOMM40 HSD17B4 PUM1 PC ZC3HAV1 RAD21 KPNA2 | 8.30e-10 | 1318 | 131 | 23 | 30463901 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SCFD2 HSPD1 MYO1D TCP1 UBR4 LLPH DHX57 FASTKD2 XRCC5 SUCLG2 OPA1 PDIA4 SEC61A2 VPS13D ALDH1L2 MTARC2 TOMM40 HADH ALDH2 PRORP HSD17B4 GOLGB1 ZC3HAV1 RAD21 | 1.79e-09 | 1496 | 131 | 24 | 32877691 |
| Pubmed | HSPD1 GPI EPRS1 MYO1D TCP1 HSPH1 PDIA4 PKM MACF1 ALDH2 HSD17B4 CAP1 | 4.56e-09 | 327 | 131 | 12 | 31409639 | |
| Pubmed | HSPD1 CYLD GPI TDRD15 TCP1 DNAJC16 LRRK2 DNAH7 CEMIP2 SEC24D PKLR PKM PC SPEN GGA1 GOLGB1 ZC3HAV1 | 6.32e-09 | 777 | 131 | 17 | 35844135 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSPD1 GPI EPRS1 TCP1 DYNC2H1 HSPH1 UBR4 LLPH XRCC5 PDIA4 SLC25A1 PKM MACF1 TOMM40 ALDH1A1 PC CAP1 | 1.10e-08 | 807 | 131 | 17 | 30575818 |
| Pubmed | HSPD1 EPRS1 MAP1B TCP1 HSPH1 STAM XRCC5 OPA1 PDIA4 PKM MACF1 DHX29 GOLGB1 CAP1 ZC3HAV1 KPNA2 | 1.16e-08 | 708 | 131 | 16 | 39231216 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | HSPD1 EPRS1 NCOA6 MAP1B TCP1 HSPH1 OPA1 GNA13 PKLR PKM PYGL ALDH1A1 ALDH2 PC RAD23B | 1.43e-08 | 621 | 131 | 15 | 22794259 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | HSPD1 GPI EPRS1 MYO1D MAP1B HSPH1 UBR4 XRCC5 SUCLG2 PDIA4 PKM PYGL HSD17B4 CAP1 KPNA2 | 2.46e-08 | 647 | 131 | 15 | 26618866 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 3.30e-08 | 182 | 131 | 9 | 30711629 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 GPI EPRS1 MAP1B RASA3 TCP1 HSPH1 UBR4 DHX57 FASTKD2 XRCC5 SUCLG2 SLC25A1 RTCA PKM MACF1 PYGL PUM1 DHX29 CAP1 ZC3HAV1 | 3.71e-08 | 1353 | 131 | 21 | 29467282 |
| Pubmed | GPI TCP1 XRCC5 PDIA4 TOMM40 HADH ALDH2 HSD17B4 CAP1 KPNA2 RAD23B | 5.00e-08 | 327 | 131 | 11 | 34428256 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | HSPD1 GPI MAP1B TCP1 HSPH1 XRCC5 PDIA4 PKM PYGL USP15 CAP1 KPNA2 RAD23B | 5.31e-08 | 495 | 131 | 13 | 28581483 |
| Pubmed | HSPD1 GPI EPRS1 DNAH3 MAP1B TCP1 HSPH1 XRCC5 SUCLG2 LGALS8 PDIA4 SEC61A2 CASKIN1 PKM CAP1 ZC3HAV1 | 6.60e-08 | 803 | 131 | 16 | 36517590 | |
| Pubmed | HSPD1 EPRS1 MYO1D MAP1B TCP1 HSPH1 XRCC5 PDIA4 SLC25A1 PKM PUM1 ZC3HAV1 | 6.80e-08 | 418 | 131 | 12 | 35338135 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 8.34e-08 | 344 | 131 | 11 | 36282215 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 GPI EPRS1 SLK MAP1B TCP1 HSPH1 STAM XRCC5 RASSF5 PKM MACF1 PC DHX29 GOLGB1 ZC3HAV1 RAD21 | 9.08e-08 | 934 | 131 | 17 | 33916271 |
| Pubmed | HSPD1 GPI EPRS1 SLK MYO1D MAP1B TCP1 HSPH1 IQSEC2 DHX57 BCL11A OPA1 CASKIN1 PKM MACF1 HADH ALDH2 PC DHX29 CAP1 CACNA2D3 | 9.52e-08 | 1431 | 131 | 21 | 37142655 | |
| Pubmed | HSPD1 EPRS1 MYO1D MAP1B TCP1 HSPH1 XRCC5 OPA1 PDIA4 ALDH1L2 SLC25A1 RTCA PKM ZC3HAV1 KPNA2 | 1.08e-07 | 725 | 131 | 15 | 27025967 | |
| Pubmed | HSPD1 TDRD15 TCP1 HSPH1 UBR4 FASTKD2 CMYA5 NEB XRCC5 OPA1 SLC25A1 PKM MACF1 PYGL CAP1 KPNA2 | 1.30e-07 | 844 | 131 | 16 | 25963833 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 1.44e-07 | 104 | 131 | 7 | 36055981 | |
| Pubmed | HSPD1 EPRS1 TCP1 DNAJC16 HSPH1 UBR4 XRCC5 PKM HSD17B4 PUM1 CAP1 ZC3HAV1 RAD21 KPNA2 | 1.45e-07 | 638 | 131 | 14 | 33239621 | |
| Pubmed | Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | 1.72e-07 | 159 | 131 | 8 | 36762613 | |
| Pubmed | 1.87e-07 | 14 | 131 | 4 | 9373155 | ||
| Pubmed | MYO1D MAP1B UBR4 DHX57 XRCC5 PDIA4 PBRM1 MACF1 PYGL PUM1 SPEN CAP1 ZC3HAV1 RAD21 | 1.92e-07 | 653 | 131 | 14 | 22586326 | |
| Pubmed | HSPD1 TET2 EPRS1 APPBP2 LLPH XRCC5 OPA1 SLC25A1 PKM HSD17B4 PUM1 PC ZC3HAV1 KPNA2 | 1.99e-07 | 655 | 131 | 14 | 35819319 | |
| Pubmed | 2.09e-07 | 377 | 131 | 11 | 25147182 | ||
| Pubmed | HSPD1 GPI EPRS1 TCP1 HSPH1 XRCC5 SUCLG2 PDIA4 SLC25A1 PKM TOMM40 HADH ALDH2 HSD17B4 USP15 KPNA2 | 2.20e-07 | 878 | 131 | 16 | 37223481 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | HSPD1 EPRS1 MAP1B HSPH1 DHX57 XRCC5 PKM HSD17B4 USP15 DHX29 KPNA2 | 2.51e-07 | 384 | 131 | 11 | 31059266 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | HSPD1 GPI MAP1B RASA3 TCP1 HSPH1 UBR4 XRCC5 OPA1 PDIA4 SEC61A2 PYGL KPNA2 | 2.84e-07 | 573 | 131 | 13 | 28330616 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | HSPD1 GPI EPRS1 MYO1D TCP1 HSPH1 IQSEC2 LGALS8 PDIA4 SLC25A1 GNA13 PKM GOLGB1 | 3.26e-07 | 580 | 131 | 13 | 35676659 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSPD1 GPI EPRS1 MYO1D MAP1B TCP1 XRCC5 PDIA4 PBRM1 GNA13 PKM MACF1 HSD17B4 PUM1 SPEN GOLGB1 KPNA2 | 3.31e-07 | 1024 | 131 | 17 | 24711643 |
| Pubmed | PDE6A TCP1 UBR4 XRCC5 PBRM1 PRORP SPEN USP15 DHX29 KPNA2 RAD23B | 3.40e-07 | 396 | 131 | 11 | 26687479 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 GPI EPRS1 SLK TCP1 HSPH1 UBR4 XRCC5 TRIP10 OPA1 SLC25A1 PKM MACF1 HSD17B4 PC GOLGB1 METTL2B ZC3HAV1 RAD21 KPNA2 | 3.61e-07 | 1415 | 131 | 20 | 28515276 |
| Pubmed | HSPD1 SLK TCP1 HSPH1 UBR4 GATM FASTKD2 STAM XRCC5 PDIA4 SEC24D ERGIC3 GNA13 MACF1 TOMM40 KLHL8 CTSL ZC3HAV1 KPNA2 | 4.27e-07 | 1297 | 131 | 19 | 33545068 | |
| Pubmed | CYLD APPBP2 SLK DNAJC16 BCL11A OPA1 PLCL2 MACF1 PUM1 SPEN USP15 | 4.45e-07 | 407 | 131 | 11 | 12693553 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | HSPD1 CHDH GATM FASTKD2 SUCLG2 OPA1 TOMM40L ALDH1L2 SLC25A1 MTARC2 TOMM40 HADH ALDH2 HSD17B4 PC DHX29 | 4.47e-07 | 926 | 131 | 16 | 20877624 |
| Pubmed | HSPD1 EPRS1 CHAF1A HSPH1 STAM PBRM1 PKM SPEN USP15 DHX29 ZC3HAV1 KPNA2 | 4.92e-07 | 503 | 131 | 12 | 16964243 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.71e-07 | 332 | 131 | 10 | 32786267 | |
| Pubmed | HSPD1 UBR4 DHX57 FASTKD2 SUCLG2 OPA1 PDIA4 ALDH1L2 MTARC2 ALDH2 PRORP HSD17B4 | 6.30e-07 | 515 | 131 | 12 | 31617661 | |
| Pubmed | INTS6L DNAJC16 STAM GPR108 CEMIP2 PDIA4 ERGIC3 SLC25A1 PYGL TOMM40 HADH HSD17B4 GGA1 GOLGB1 ZC3HAV1 RAD21 | 6.43e-07 | 952 | 131 | 16 | 38569033 | |
| Pubmed | HSPD1 EPRS1 MYO1D MAP1B TCP1 DNAJC16 HSPH1 DHX57 FASTKD2 XRCC5 OPA1 WDR87 PKM HSD17B4 PC USP15 ZC3HAV1 KPNA2 RAD23B | 6.59e-07 | 1335 | 131 | 19 | 29229926 | |
| Pubmed | 7.30e-07 | 132 | 131 | 7 | 22496890 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSPD1 GPI EPRS1 DNAH3 SLK TCP1 HSPH1 XRCC5 SUCLG2 PDIA4 PBRM1 LRP5 MACF1 DHX29 GOLGB1 | 7.73e-07 | 847 | 131 | 15 | 35235311 |
| Pubmed | SCFD2 HSPD1 CYLD DYNC2H1 DNAJC16 HSPH1 UBR4 FASTKD2 XRCC5 CEMIP2 PDIA4 SEC61A2 MACF1 SEMA6A ALDH2 DHX29 GOLGB1 EPHA7 ZC3HAV1 RAD21 | 7.83e-07 | 1487 | 131 | 20 | 33957083 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 7.87e-07 | 344 | 131 | 10 | 30333137 | |
| Pubmed | EPRS1 HSPH1 UBR4 XRCC5 SUCLG2 PDIA4 SLC25A1 HADH ALDH2 HSD17B4 PUM1 ZC3HAV1 | 9.21e-07 | 534 | 131 | 12 | 35032548 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 9.94e-07 | 353 | 131 | 10 | 27545878 | |
| Pubmed | HSPD1 GATM SUCLG2 OPA1 SLC25A1 PKM LRP5 MTARC2 TOMM40 HADH ALDH2 PC | 1.08e-06 | 542 | 131 | 12 | 14651853 | |
| Pubmed | HSPD1 GPI EPRS1 NCOA6 MYO1D TCP1 HSPH1 XRCC5 OPA1 SEC61A2 WDR87 SLC25A1 PKM USP15 CAP1 ZC3HAV1 KPNA2 RAD23B | 1.09e-06 | 1247 | 131 | 18 | 27684187 | |
| Pubmed | EPRS1 NCOA6 SLK MAP1B TCP1 SLC25A1 PKM PC SPEN USP15 ZC3HAV1 KPNA2 | 1.23e-06 | 549 | 131 | 12 | 38280479 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 1.29e-06 | 281 | 131 | 9 | 30455355 | |
| Pubmed | 1.31e-06 | 144 | 131 | 7 | 35681168 | ||
| Pubmed | 1.39e-06 | 92 | 131 | 6 | 35530310 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 GPI EPRS1 SLK MAP1B TCP1 HSPH1 UBR4 XRCC5 PDIA4 PKM MACF1 PYGL CAP1 ZC3HAV1 KPNA2 RAD23B | 1.60e-06 | 1149 | 131 | 17 | 35446349 |
| Pubmed | HSPD1 CYLD TET2 NCOA6 SLK MYO1D DNAH10 TCP1 HSPH1 UBR4 LLPH BCL11A XRCC5 PDIA4 PBRM1 PUM1 SPEN ZC3HAV1 RAD21 | 1.80e-06 | 1429 | 131 | 19 | 35140242 | |
| Pubmed | 1.96e-06 | 153 | 131 | 7 | 27462432 | ||
| Pubmed | HSPD1 FASTKD2 SUCLG2 OPA1 MTARC2 HADH ALDH2 PRORP HSD17B4 PC | 2.02e-06 | 382 | 131 | 10 | 29222160 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | HSPD1 CHDH GATM FASTKD2 SUCLG2 OPA1 TOMM40L ALDH1L2 SLC25A1 MTARC2 TOMM40 HADH ALDH2 HSD17B4 PC DHX29 | 2.21e-06 | 1047 | 131 | 16 | 18614015 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 EPRS1 SLK TCP1 HSPH1 UBR4 CMYA5 XRCC5 TRIP10 PDIA4 PARP6 SEC24D PKM MACF1 PYGL USP15 CAP1 KPNA2 RAD23B | 2.35e-06 | 1455 | 131 | 19 | 22863883 |
| Pubmed | HSPD1 EPRS1 MYO1D SEC24D SLC25A1 PYGL TOMM40 ALCAM PC GOLGB1 KPNA2 | 2.40e-06 | 484 | 131 | 11 | 31995728 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | HSPD1 TCP1 DHX57 XRCC5 PBRM1 SLC25A1 PKM PRORP PC ZC3HAV1 KPNA2 | 2.49e-06 | 486 | 131 | 11 | 30940648 |
| Pubmed | HSPD1 GPI TET2 EPRS1 TCP1 UBR4 FASTKD2 XRCC5 PDIA4 PKM MACF1 HSD17B4 GOLGB1 | 3.11e-06 | 711 | 131 | 13 | 33022573 | |
| Pubmed | 3.17e-06 | 234 | 131 | 8 | 36243803 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.38e-06 | 316 | 131 | 9 | 31665637 | |
| Pubmed | 3.74e-06 | 320 | 131 | 9 | 28685749 | ||
| Pubmed | The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. | 3.96e-06 | 110 | 131 | 6 | 18307411 | |
| Pubmed | 3.96e-06 | 110 | 131 | 6 | 25940091 | ||
| Pubmed | TET2 EPRS1 NCOA6 TCP1 INPP5D HSPH1 BCL11A PDIA4 ERGIC3 PKM PYGL HSD17B4 SPEN CAP1 RAD21 RAD23B | 4.28e-06 | 1103 | 131 | 16 | 34189442 | |
| Pubmed | 4.31e-06 | 244 | 131 | 8 | 28902428 | ||
| Pubmed | Proteomic analysis of the mouse liver mitochondrial inner membrane. | 4.78e-06 | 175 | 131 | 7 | 12865426 | |
| Pubmed | 4.86e-06 | 114 | 131 | 6 | 28245920 | ||
| Pubmed | 5.18e-06 | 425 | 131 | 10 | 21081503 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HSPD1 EPRS1 TCP1 HSPH1 UBR4 XRCC5 OPA1 SEC61A2 ERGIC3 SLC25A1 PKM PYGL HSD17B4 PUM1 USP15 KPNA2 RAD23B | 5.31e-06 | 1257 | 131 | 17 | 37317656 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 5.55e-06 | 179 | 131 | 7 | 36261009 | |
| Pubmed | 5.62e-06 | 67 | 131 | 5 | 30669930 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 6.13e-06 | 256 | 131 | 8 | 32698014 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | HSPD1 CHDH GATM FASTKD2 SUCLG2 OPA1 VPS13D TOMM40L ALDH1L2 SLC25A1 MTARC2 TOMM40 HADH ALDH2 PRORP PC | 6.20e-06 | 1136 | 131 | 16 | 34800366 |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 6.23e-06 | 119 | 131 | 6 | 35776542 | |
| Pubmed | Mitochondrial protein interactome elucidated by chemical cross-linking mass spectrometry. | 6.54e-06 | 343 | 131 | 9 | 28130547 | |
| Pubmed | CYLD TET2 EPRS1 HSPH1 IQSEC2 UBR4 GATM STAM CMYA5 RYR3 RALBP1 PKM MACF1 HSD17B4 PC CTSL RAD23B | 7.08e-06 | 1285 | 131 | 17 | 35914814 | |
| Pubmed | circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma. | 8.02e-06 | 72 | 131 | 5 | 36811957 | |
| Pubmed | HSPD1 TET2 EPRS1 MAP1B TCP1 HSPH1 UBR4 XRCC5 PKM ZC3HAV1 KPNA2 | 8.19e-06 | 551 | 131 | 11 | 34728620 | |
| Pubmed | HSPD1 GPI EPRS1 PDE6A MAP1B PDE6B TCP1 PKM ALDH1A1 HADH CAP1 | 8.33e-06 | 552 | 131 | 11 | 36293380 | |
| Pubmed | 8.36e-06 | 449 | 131 | 10 | 31732153 | ||
| Pubmed | 9.18e-06 | 74 | 131 | 5 | 35102251 | ||
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | HSPD1 MYO1D TCP1 HSPH1 XRCC5 SUCLG2 SLC25A1 PKM TOMM40 PC KPNA2 | 1.03e-05 | 565 | 131 | 11 | 33567341 |
| Pubmed | 1.04e-05 | 130 | 131 | 6 | 12421765 | ||
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | 1.14e-05 | 200 | 131 | 7 | 35546148 | |
| Pubmed | SCFD2 CYLD EPRS1 FASTKD2 SUCLG2 ALDH1L2 RTCA SEMA6A HADH ALDH2 PRORP RAD23B | 1.18e-05 | 686 | 131 | 12 | 28380382 | |
| Pubmed | 1.21e-05 | 281 | 131 | 8 | 26725010 | ||
| Pubmed | HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. | 1.28e-05 | 135 | 131 | 6 | 23874603 | |
| Pubmed | 1.34e-05 | 136 | 131 | 6 | 22304920 | ||
| Pubmed | DNAJC16 CHAF1A HSPH1 LLPH DHX57 LGALS8 GREB1L PBRM1 PPP3CC SLC25A1 MACF1 TOMM40 SPEN DHX29 GOLGB1 ZC3HAV1 RAD21 RAD23B | 1.36e-05 | 1497 | 131 | 18 | 31527615 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 11960989 | ||
| Pubmed | Quantitative proteome analysis of multidrug resistance in human ovarian cancer cell line. | 1.41e-05 | 2 | 131 | 2 | 20082317 | |
| Interaction | BIRC3 interactions | HSPD1 GPI EPRS1 MYO1D DNAH10 TCP1 DYNC2H1 CHAF1A HSPH1 UBR4 FASTKD2 CMYA5 XRCC5 PDIA4 PBRM1 PIM1 PKM TOMM40 ALDH2 HSD17B4 PUM1 PC SPEN USP15 DHX29 CAP1 ZC3HAV1 RAD21 KPNA2 RAD23B | 1.03e-09 | 1334 | 129 | 30 | int:BIRC3 |
| Interaction | KCNA3 interactions | HSPD1 EPRS1 MYO1D MAP1B TCP1 HSPH1 LRRK2 STAM XRCC5 OPA1 PDIA4 PKM MACF1 PYGL SPEN DHX29 GOLGB1 CAP1 ZC3HAV1 KPNA2 | 6.84e-07 | 871 | 129 | 20 | int:KCNA3 |
| Interaction | B3GNT2 interactions | HSPD1 EPRS1 MYO1D MAP1B TCP1 HSPH1 XRCC5 LCN6 PDIA4 SLC25A1 PKM PUM1 PC EPHA7 ZC3HAV1 | 2.05e-06 | 542 | 129 | 15 | int:B3GNT2 |
| Interaction | LOXL2 interactions | HSPD1 GPI EPRS1 MYO1D TCP1 HSPH1 PDIA4 PKM MACF1 ALDH2 HSD17B4 CAP1 EPHA7 | 2.36e-06 | 410 | 129 | 13 | int:LOXL2 |
| Interaction | BAG1 interactions | GPI TCP1 LRRK2 XRCC5 PDIA4 PYGL TOMM40 ALDH1A1 HADH ALDH2 HSD17B4 CAP1 KPNA2 RAD23B | 3.50e-06 | 494 | 129 | 14 | int:BAG1 |
| Interaction | MCM2 interactions | HSPD1 TDRD15 TCP1 CHAF1A HSPH1 UBR4 FASTKD2 CMYA5 NEB XRCC5 OPA1 PDIA4 SLC25A1 PKM MACF1 PYGL USP15 GGA1 CAP1 RAD21 KPNA2 | 4.98e-06 | 1081 | 129 | 21 | int:MCM2 |
| Interaction | IFITM3 interactions | CYLD GPI MYO1D UBR4 STAM XRCC5 CEMIP2 PDIA4 SEC24D ERGIC3 SEMA6A GOLGB1 EPHA7 ZC3HAV1 | 5.39e-06 | 513 | 129 | 14 | int:IFITM3 |
| Interaction | IMMP2L interactions | HSPD1 UBR4 DHX57 FASTKD2 SUCLG2 OPA1 PDIA4 ALDH1L2 MTARC2 ALDH2 PRORP HSD17B4 | 6.81e-06 | 384 | 129 | 12 | int:IMMP2L |
| Interaction | SAR1B interactions | HSPD1 TCP1 DNAJC16 XRCC5 PDIA4 SEC24D PKM PYGL PC GOLGB1 ZC3HAV1 | 1.18e-05 | 339 | 129 | 11 | int:SAR1B |
| Interaction | LRRK2 interactions | HSPD1 EPRS1 MYO1D MAP1B HSPH1 LRRK2 SUCLG2 OPA1 LGALS8 PDIA4 GNA13 USP15 CAP1 | 1.82e-05 | 496 | 129 | 13 | int:LRRK2 |
| Interaction | CCDC8 interactions | HSPD1 EPRS1 MYO1D MAP1B TCP1 IQSEC2 XRCC5 PDIA4 GNA13 PKM MACF1 HSD17B4 PUM1 GOLGB1 KPNA2 | 2.01e-05 | 656 | 129 | 15 | int:CCDC8 |
| Interaction | PGK1 interactions | 2.46e-05 | 367 | 129 | 11 | int:PGK1 | |
| Interaction | HDAC6 interactions | HSPD1 CYLD GPI EPRS1 MYO1D TCP1 HSPH1 IQSEC2 LRRK2 XRCC5 LGALS8 PDIA4 PBRM1 SLC25A1 GNA13 PKM GOLGB1 RAD23B | 2.64e-05 | 929 | 129 | 18 | int:HDAC6 |
| Interaction | NR2C2 interactions | HSPD1 EPRS1 TCP1 CHAF1A HSPH1 UBR4 LLPH FASTKD2 XRCC5 SUCLG2 OPA1 PBRM1 SLC25A1 PKLR PKM PYGL TOMM40 HSD17B4 PUM1 PC ZC3HAV1 RAD21 KPNA2 | 2.65e-05 | 1403 | 129 | 23 | int:NR2C2 |
| Interaction | AGR2 interactions | HSPD1 GPI EPRS1 TCP1 DYNC2H1 HSPH1 UBR4 LLPH XRCC5 PDIA4 SH2D1B SLC25A1 PKM MACF1 TOMM40 ALDH1A1 PC CAP1 | 2.83e-05 | 934 | 129 | 18 | int:AGR2 |
| Interaction | RAPSN interactions | 2.91e-05 | 28 | 129 | 4 | int:RAPSN | |
| Interaction | PHB1 interactions | HSPD1 CYLD EPRS1 MYO1D MAP1B TCP1 HSPH1 TMEM63B XRCC5 OPA1 PDIA4 ALDH1L2 SLC25A1 RTCA PKM TOMM40 USP15 CTSL ZC3HAV1 KPNA2 | 3.02e-05 | 1123 | 129 | 20 | int:PHB1 |
| Interaction | ASS1 interactions | 3.35e-05 | 192 | 129 | 8 | int:ASS1 | |
| Interaction | MKRN2 interactions | EPRS1 MAP1B DYNC2H1 DHX57 OPA1 PKM MACF1 SEMA6A PUM1 EPHA7 ZC3HAV1 | 3.81e-05 | 385 | 129 | 11 | int:MKRN2 |
| Interaction | HSP90AB1 interactions | HSPD1 CYLD TET2 PDE8A MAP1B TCP1 HSPH1 UBR4 LRRK2 NEB SLC25A1 PKM SPEN USP15 CAP1 RAD21 KPNA2 RAD23B | 4.06e-05 | 960 | 129 | 18 | int:HSP90AB1 |
| Interaction | NFX1 interactions | HSPD1 EPRS1 MAP1B HSPH1 DHX57 XRCC5 PKM HSD17B4 USP15 DHX29 ZC3HAV1 KPNA2 | 4.60e-05 | 466 | 129 | 12 | int:NFX1 |
| Interaction | HADH interactions | 4.73e-05 | 148 | 129 | 7 | int:HADH | |
| Interaction | CLEC4D interactions | 4.73e-05 | 261 | 129 | 9 | int:CLEC4D | |
| Interaction | RHOJ interactions | PDE8A MYO1D RASA3 FASTKD2 STAM TRIP10 CEMIP2 SLC25A1 LRP5 MACF1 TOMM40 PRORP EPHA7 ZC3HAV1 | 5.54e-05 | 633 | 129 | 14 | int:RHOJ |
| Interaction | RUFY1 interactions | HSPD1 EPRS1 TCP1 HSPH1 XRCC5 OPA1 RALBP1 SLC25A1 PKM PYGL PC KPNA2 | 5.65e-05 | 476 | 129 | 12 | int:RUFY1 |
| Interaction | ATP1A1 interactions | HSPD1 CYLD GPI CACNA1D EPRS1 TCP1 TMEM63B DHX57 XRCC5 SLC25A1 TOMM40 ALDH1A1 PC | 8.30e-05 | 575 | 129 | 13 | int:ATP1A1 |
| Interaction | WWP2 interactions | EPRS1 HSPH1 DHX57 STAM XRCC5 TRIP10 SEC24D SLC25A1 SCN5A PKM PC USP15 DHX29 ZC3HAV1 KPNA2 RAD23B | 9.38e-05 | 840 | 129 | 16 | int:WWP2 |
| Interaction | POU5F1 interactions | HSPD1 PDE6A TCP1 UBR4 LRRK2 XRCC5 PBRM1 PRORP USP15 DHX29 RAD21 KPNA2 RAD23B | 9.70e-05 | 584 | 129 | 13 | int:POU5F1 |
| Interaction | IFITM1 interactions | GPI MYO1D UBR4 STAM PDIA4 SEC24D SLC25A1 GOLGB1 EPHA7 ZC3HAV1 | 9.75e-05 | 355 | 129 | 10 | int:IFITM1 |
| Interaction | MGAT4C interactions | 9.99e-05 | 38 | 129 | 4 | int:MGAT4C | |
| Interaction | LGALS9 interactions | HSPD1 EPRS1 MYO1D TMEM63B LGALS8 SEC24D SLC25A1 PYGL TOMM40 ALCAM PC GOLGB1 KPNA2 | 1.04e-04 | 588 | 129 | 13 | int:LGALS9 |
| Interaction | GOLGA4 interactions | 1.05e-04 | 226 | 129 | 8 | int:GOLGA4 | |
| Interaction | ATXN3 interactions | HSPD1 EPRS1 TCP1 HSPH1 XRCC5 WDR87 SLC25A1 PKM PC KPNA2 RAD23B | 1.23e-04 | 439 | 129 | 11 | int:ATXN3 |
| Interaction | TOMM6 interactions | 1.35e-04 | 41 | 129 | 4 | int:TOMM6 | |
| Interaction | RNF113A interactions | HSPD1 TET2 EPRS1 APPBP2 LLPH XRCC5 OPA1 SLC25A1 PKM HSD17B4 PUM1 PC ZC3HAV1 KPNA2 | 1.42e-04 | 692 | 129 | 14 | int:RNF113A |
| Interaction | PSMD14 interactions | HSPD1 CYLD DNAH10 TCP1 HSPH1 UBR4 CMYA5 VPS13D PKM HADH USP15 RAD23B | 1.47e-04 | 527 | 129 | 12 | int:PSMD14 |
| Interaction | NAA40 interactions | HSPD1 GPI EPRS1 SLK MAP1B TCP1 HSPH1 STAM XRCC5 RASSF5 PKM MACF1 PC DHX29 GOLGB1 ZC3HAV1 RAD21 | 1.69e-04 | 978 | 129 | 17 | int:NAA40 |
| Interaction | CFTR interactions | HSPD1 GPI EPRS1 MYO1D MAP1B HSPH1 UBR4 FASTKD2 XRCC5 SUCLG2 RYR3 PDIA4 SEC61A2 SLC25A1 PKM MACF1 PYGL HSD17B4 PUM1 GGA1 CAP1 KPNA2 | 1.71e-04 | 1480 | 129 | 22 | int:CFTR |
| Interaction | FMR1 interactions | CYLD EPRS1 MAP1B IQSEC2 UBR4 DHX57 BCL11A PBRM1 CASKIN1 MACF1 PUM1 ZC3HAV1 | 1.72e-04 | 536 | 129 | 12 | int:FMR1 |
| Interaction | PLOD3 interactions | 1.79e-04 | 183 | 129 | 7 | int:PLOD3 | |
| Interaction | C11orf52 interactions | 1.79e-04 | 311 | 129 | 9 | int:C11orf52 | |
| Interaction | BAG2 interactions | CYLD NCOA6 SLK MAP1B DNAJC16 LRRK2 STAM VPS13D TXNRD3 TOMM40 PUM1 SPEN CTSL | 1.81e-04 | 622 | 129 | 13 | int:BAG2 |
| Interaction | CALM1 interactions | CYLD DRD2 MYO1D TCP1 IQSEC2 UBR4 LRRK2 NEB PDIA4 VPS13D PPP3CC SCN5A RAD23B | 1.92e-04 | 626 | 129 | 13 | int:CALM1 |
| Interaction | IFI16 interactions | HSPD1 MAP1B TCP1 HSPH1 LLPH DHX57 XRCC5 PDIA4 PBRM1 PKM USP15 DHX29 ZC3HAV1 KPNA2 | 1.96e-04 | 714 | 129 | 14 | int:IFI16 |
| Interaction | NOS2 interactions | 1.97e-04 | 186 | 129 | 7 | int:NOS2 | |
| Interaction | KCTD13 interactions | HSPD1 GPI EPRS1 SLK MYO1D MAP1B TCP1 HSPH1 IQSEC2 DHX57 BCL11A OPA1 CASKIN1 PKM MACF1 HADH ALDH2 PC DHX29 CAP1 CACNA2D3 | 2.04e-04 | 1394 | 129 | 21 | int:KCTD13 |
| Interaction | PSMD6 interactions | 2.07e-04 | 317 | 129 | 9 | int:PSMD6 | |
| Interaction | RPN1 interactions | MAP1B TCP1 DNAJC16 TMEM63B SUCLG2 PDIA4 ERGIC3 SLC25A1 PKM TOMM40 PC CTSL GOLGB1 EPHA7 ZC3HAV1 | 2.25e-04 | 814 | 129 | 15 | int:RPN1 |
| Interaction | PAGE4 interactions | 2.28e-04 | 253 | 129 | 8 | int:PAGE4 | |
| Interaction | NPM1 interactions | CYLD EPRS1 MAP1B TCP1 CHAF1A MYT1 DHX57 NEB XRCC5 OPA1 PBRM1 WDR87 CASKIN1 PKM PC USP15 GGA1 DHX29 ZC3HAV1 | 2.29e-04 | 1201 | 129 | 19 | int:NPM1 |
| Interaction | LRPPRC interactions | HSPD1 EPRS1 SLK MAP1B HSPH1 FASTKD2 ASAH1 SLC25A1 TOMM40 HADH ALDH2 PRORP USP15 RAD21 KPNA2 | 2.67e-04 | 827 | 129 | 15 | int:LRPPRC |
| Interaction | SOX2 interactions | HSPD1 GPI TET2 EPRS1 NCOA6 MAP1B TCP1 DNAJC16 UBR4 DHX57 XRCC5 PBRM1 SLC25A1 MACF1 ALDH2 SPEN USP15 CAP1 EPHA7 RAD21 RAD23B | 2.67e-04 | 1422 | 129 | 21 | int:SOX2 |
| Interaction | YWHAQ interactions | CYLD TET2 NCOA6 SLK TCP1 CHAF1A HSPH1 IQSEC2 LRRK2 NEB DNAH7 VPS13D SLC25A1 PKM MACF1 PUM1 PC GOLGB1 | 2.75e-04 | 1118 | 129 | 18 | int:YWHAQ |
| Interaction | UBE2M interactions | HSPD1 GPI MAP1B TCP1 HSPH1 XRCC5 PDIA4 PKM PYGL USP15 CAP1 KPNA2 RAD23B | 2.81e-04 | 651 | 129 | 13 | int:UBE2M |
| Interaction | PHLPP1 interactions | 2.97e-04 | 333 | 129 | 9 | int:PHLPP1 | |
| Interaction | SIRT7 interactions | MYO1D MAP1B UBR4 DHX57 XRCC5 PDIA4 PBRM1 MACF1 PYGL PUM1 SPEN CAP1 ZC3HAV1 RAD21 | 2.98e-04 | 744 | 129 | 14 | int:SIRT7 |
| Interaction | VCP interactions | HSPD1 CYLD MYO1D TCP1 HSPH1 UBR4 NEB XRCC5 SUCLG2 TRIP10 RYR3 SEC24D VPS13D PKM ALDH1A1 HADH ALDH2 USP15 GGA1 CAP1 RAD23B | 3.02e-04 | 1435 | 129 | 21 | int:VCP |
| Interaction | UBR4 interactions | 3.04e-04 | 334 | 129 | 9 | int:UBR4 | |
| Interaction | SLC25A46 interactions | 3.27e-04 | 267 | 129 | 8 | int:SLC25A46 | |
| Interaction | CUL7 interactions | HSPD1 GPI EPRS1 MAP1B TCP1 XRCC5 PDIA4 GNA13 PKM MACF1 HSD17B4 SPEN GOLGB1 EPHA7 KPNA2 | 3.35e-04 | 845 | 129 | 15 | int:CUL7 |
| Interaction | EFTUD2 interactions | HSPD1 CYLD GPI EPRS1 SLK TCP1 CHAF1A HSPH1 UBR4 XRCC5 TRIP10 OPA1 SLC25A1 PKM MACF1 HSD17B4 PC GOLGB1 ZC3HAV1 RAD21 KPNA2 | 3.44e-04 | 1449 | 129 | 21 | int:EFTUD2 |
| Interaction | HSPA4 interactions | HSPD1 CYLD APPBP2 MAP1B TCP1 HSPH1 LRRK2 XRCC5 PDIA4 PIM1 TOMM40 PC KPNA2 | 3.55e-04 | 667 | 129 | 13 | int:HSPA4 |
| Interaction | MARCHF5 interactions | 3.57e-04 | 205 | 129 | 7 | int:MARCHF5 | |
| Interaction | USP48 interactions | HSPD1 GPI EPRS1 SLK PDE6A MAP1B PDE6B TCP1 SEC24D PKM HADH CAP1 ZC3HAV1 | 3.60e-04 | 668 | 129 | 13 | int:USP48 |
| Interaction | FGD5 interactions | 3.78e-04 | 207 | 129 | 7 | int:FGD5 | |
| Interaction | OPTN interactions | 3.91e-04 | 422 | 129 | 10 | int:OPTN | |
| Interaction | RAC2 interactions | PDE8A RASA3 CEMIP2 VPS13D SLC25A1 LRP5 MACF1 MTARC2 TOMM40 PRORP GOLGB1 EPHA7 ZC3HAV1 | 3.92e-04 | 674 | 129 | 13 | int:RAC2 |
| Interaction | SQSTM1 interactions | CYLD EPRS1 SLK MAP1B TCP1 CHAF1A CHDH HSPH1 LRRK2 FASTKD2 STAM SUCLG2 SLC25A1 TOMM40 KLHL8 GGA1 GOLGB1 ZC3HAV1 KPNA2 | 4.06e-04 | 1257 | 129 | 19 | int:SQSTM1 |
| Interaction | SUMO2 interactions | HSPD1 EPRS1 TCP1 CHAF1A UBR4 LRRK2 XRCC5 PDIA4 PBRM1 PKM RAD21 KPNA2 | 4.19e-04 | 591 | 129 | 12 | int:SUMO2 |
| Interaction | PSMB7 interactions | 4.24e-04 | 211 | 129 | 7 | int:PSMB7 | |
| Interaction | PCDH7 interactions | 4.39e-04 | 279 | 129 | 8 | int:PCDH7 | |
| Interaction | RHOU interactions | MYO1D FASTKD2 STAM CEMIP2 RALBP1 SLC25A1 GNA13 HSD17B13 MACF1 PRORP EPHA7 | 4.44e-04 | 510 | 129 | 11 | int:RHOU |
| Interaction | GSK3B interactions | HSPD1 CYLD GPI MAP1B TCP1 HSPH1 LRRK2 PDIA4 VPS13D PPP3CC PKM MACF1 PYGL HSD17B4 CAP1 | 4.45e-04 | 868 | 129 | 15 | int:GSK3B |
| Interaction | ZNF598 interactions | HSPD1 EPRS1 MAP1B TCP1 HSPH1 SLC25A1 PKM TOMM40 CAP1 ZC3HAV1 | 4.96e-04 | 435 | 129 | 10 | int:ZNF598 |
| Cytoband | 9q21.13 | 4.99e-05 | 25 | 131 | 3 | 9q21.13 | |
| GeneFamily | Dyneins, axonemal | 6.97e-05 | 17 | 87 | 3 | 536 | |
| GeneFamily | Aldehyde dehydrogenases | 9.86e-05 | 19 | 87 | 3 | 398 | |
| GeneFamily | Phosphodiesterases | 2.02e-04 | 24 | 87 | 3 | 681 | |
| GeneFamily | Glycosyltransferase family 8 | 8.06e-04 | 9 | 87 | 2 | 436 | |
| GeneFamily | Chaperonins | 2.31e-03 | 15 | 87 | 2 | 587 | |
| GeneFamily | DEAH-box helicases | 2.63e-03 | 16 | 87 | 2 | 500 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.97e-03 | 17 | 87 | 2 | 684 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | HSPD1 EPRS1 NCOA6 APPBP2 TCP1 HSPH1 FASTKD2 BCL11A XRCC5 OPA1 RYR3 PPP3CC RALBP1 PLCL2 MACF1 ALCAM HADH PUM1 USP15 CAP1 KPNA2 | 5.77e-07 | 1215 | 130 | 21 | M41122 |
| Coexpression | IBRAHIM_NRF1_UP | HSPD1 TCP1 HSPH1 STAM RYR3 SEC24D RTCA PKM ALDH2 CTSL RAD23B | 8.27e-06 | 420 | 130 | 11 | M42509 |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | MAP1B BCL11A TRIP10 PPP3CC WDR87 PKM MACF1 SEMA6A ALCAM REM2 CFAP69 | 1.64e-05 | 452 | 130 | 11 | M18685 |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 2.27e-05 | 384 | 130 | 10 | M1865 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | EPRS1 SLK HSPH1 LLPH OPA1 LGALS8 PBRM1 ASAH1 RALBP1 ALDH2 DHX29 GOLGB1 RAD21 | 2.41e-05 | 656 | 130 | 13 | M18979 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | HSPD1 EPRS1 CHAF1A XRCC5 LGALS8 PIM1 SLC25A1 ALDH1A1 HADH HSD17B4 CTSL KPNA2 RAD23B | 2.95e-05 | 669 | 130 | 13 | M18635 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 NCOA6 APPBP2 LLPH CEMIP2 PDIA4 PKM ALDH1A1 PUM1 DHX29 EPHA7 | 3.07e-05 | 484 | 130 | 11 | MM999 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HMGL | INTS6L HSPD1 FGD2 INPP5D HSPH1 LRRK2 GATM SUCLG2 ASAH1 PYGL CTSL ZC3HAV1 | 3.15e-05 | 577 | 130 | 12 | M39051 |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 3.35e-05 | 402 | 130 | 10 | MM1248 | |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 3.45e-05 | 181 | 130 | 7 | M39225 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 3.65e-05 | 250 | 130 | 8 | M11318 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP | 5.01e-05 | 192 | 130 | 7 | M6592 | |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | HSPH1 GATM BCL11A STAM CEMIP2 ASAH1 PIM1 GNA13 ALDH2 HSD11B1 HSD17B4 | 5.10e-05 | 512 | 130 | 11 | M4508 |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 6.49e-05 | 200 | 130 | 7 | M3510 | |
| Coexpression | GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 6.49e-05 | 200 | 130 | 7 | M7535 | |
| Coexpression | GSE40273_EOS_KO_VS_WT_TREG_UP | 6.49e-05 | 200 | 130 | 7 | M9127 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 9.34e-05 | 212 | 130 | 7 | M39221 | |
| Coexpression | FAELT_B_CLL_WITH_VH3_21_DN | 1.03e-04 | 49 | 130 | 4 | M7218 | |
| Coexpression | SIRNA_EIF4GI_UP | 1.13e-04 | 95 | 130 | 5 | M2847 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.16e-04 | 467 | 130 | 10 | M1347 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | HSPD1 GPI HSPH1 BCL11A STAM OPA1 LGALS8 SEC61A2 ASAH1 PLCL2 HADH ALDH2 USP15 CAP1 EPHA7 KPNA2 RAD23B | 1.50e-04 | 1248 | 130 | 17 | M17728 |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP | 1.51e-04 | 160 | 130 | 6 | M8183 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D4 | 1.51e-04 | 54 | 130 | 4 | M15468 | |
| Coexpression | BORCZUK_MALIGNANT_MESOTHELIOMA_UP | 1.63e-04 | 310 | 130 | 8 | M10236 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN | 1.84e-04 | 166 | 130 | 6 | M6110 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | HSPD1 EPRS1 TCP1 CHAF1A MYT1 HSPH1 STAM XRCC5 RALBP1 PKLR TOMM40 ALDH1A1 HADH HSD17B4 PC USP15 RAD23B | 1.86e-04 | 1271 | 130 | 17 | M39197 |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | CYLD MAP1B DNAJC16 TMEM63B FASTKD2 CEMIP2 CEACAM1 LGALS8 SEC24D PPP3CC GNA13 RTCA USP15 EPHA7 ZC3HAV1 | 1.91e-04 | 1033 | 130 | 15 | M4196 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | INTS6L CACNA1D RASA3 GATM PM20D1 DNAH7 GREB1L GXYLT2 PPP3CC HSD17B13 PYGL ALDH1A1 HADH ALDH2 KLHL8 EPHA7 ZC3HAV1 | 7.51e-06 | 803 | 129 | 17 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | INTS6L CACNA1D RASA3 GATM PM20D1 DNAH7 GREB1L GXYLT2 HSD17B13 ALDH1A1 KLHL8 EPHA7 | 8.63e-06 | 414 | 129 | 12 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5- CD45R+, Peritoneal Cavity, avg-2 | PDE8A FGD2 RASA3 LRRK2 BCL11A CEACAM1 PDIA4 PPP3CC MACF1 ALDH2 | 4.11e-05 | 337 | 129 | 10 | GSM538228_500 |
| CoexpressionAtlas | B cells, B1a.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21/35-, Spleen, avg-3 | PDE8A MYO1D FGD2 LRRK2 BCL11A CEACAM1 PDIA4 PPP3CC ALCAM ALDH2 | 4.54e-05 | 341 | 129 | 10 | GSM538225_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | INTS6L CACNA1D RASA3 GATM PM20D1 GREB1L GXYLT2 ALDH1A1 KLHL8 EPHA7 ZC3HAV1 | 5.46e-05 | 422 | 129 | 11 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.33e-05 | 115 | 129 | 6 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | INTS6L CACNA1D RASA3 GATM PM20D1 DNAH7 LGALS8 GREB1L GXYLT2 PPP3CC ALDH1A1 ALDH2 KLHL8 EPHA7 ZC3HAV1 | 1.12e-04 | 804 | 129 | 15 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 1.92e-04 | 137 | 129 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-1 | 1.99e-04 | 332 | 129 | 9 | GSM538230_500 | |
| CoexpressionAtlas | Stem Cells, SC.MEP.BM, Lineage- Kit+ Sca1- CD34- FcgR-/low, Bone marrow, avg-2 | 2.11e-04 | 89 | 129 | 5 | GSM791108_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305 | 2.25e-04 | 266 | 129 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | INTS6L APPBP2 MAP1B BCL11A CEMIP2 PBRM1 GNA13 PUM1 EPHA7 RAD23B | 2.36e-04 | 417 | 129 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.49e-04 | 270 | 129 | 8 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 2.80e-04 | 426 | 129 | 10 | GSM605859_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | PDE8A MAP1B DNAJC16 GATM PM20D1 CEMIP2 GREB1L PDIA4 PPP3CC ASAH1 ALDH1A1 HADH ALDH2 EPHA7 ZC3HAV1 | 3.12e-04 | 884 | 129 | 15 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | PDE8A MAP1B GATM PM20D1 GREB1L ALDH1A1 HADH CTSL EPHA7 ZC3HAV1 | 3.18e-04 | 433 | 129 | 10 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_500 | 3.25e-04 | 54 | 129 | 4 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k1_500 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-09 | 168 | 131 | 9 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-09 | 168 | 131 | 9 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-09 | 169 | 131 | 9 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-09 | 169 | 131 | 9 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 8.57e-08 | 187 | 131 | 8 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 195 | 131 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-07 | 195 | 131 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-07 | 160 | 131 | 7 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.43e-06 | 188 | 131 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 1.43e-06 | 188 | 131 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.65e-06 | 192 | 131 | 7 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 194 | 131 | 7 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.83e-06 | 195 | 131 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.83e-06 | 195 | 131 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 197 | 131 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 197 | 131 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 197 | 131 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-06 | 197 | 131 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 200 | 131 | 7 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.16e-06 | 200 | 131 | 7 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-06 | 200 | 131 | 7 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-06 | 165 | 131 | 6 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 169 | 131 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.16e-05 | 171 | 131 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 172 | 131 | 6 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 172 | 131 | 6 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 172 | 131 | 6 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 175 | 131 | 6 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.51e-05 | 179 | 131 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 1.56e-05 | 180 | 131 | 6 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 183 | 131 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 183 | 131 | 6 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 184 | 131 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.82e-05 | 185 | 131 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.82e-05 | 185 | 131 | 6 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-05 | 185 | 131 | 6 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-05 | 186 | 131 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 186 | 131 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 188 | 131 | 6 | 9fc3f17045606f1fe29d296326da9482db58433b | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 188 | 131 | 6 | 1ff13434dfe60c8184d5f33041e325eca41392bc | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.05e-05 | 189 | 131 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.05e-05 | 189 | 131 | 6 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 2.18e-05 | 191 | 131 | 6 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-05 | 191 | 131 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.24e-05 | 192 | 131 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.24e-05 | 192 | 131 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.24e-05 | 192 | 131 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.31e-05 | 193 | 131 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.31e-05 | 193 | 131 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.31e-05 | 193 | 131 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 193 | 131 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | control-Myeloid-mDC|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.31e-05 | 193 | 131 | 6 | 5e43024763932a679c33d83cf8f606612bc0f600 | |
| ToppCell | HSPCs-Ery_prog.|World / Lineage and Cell class | 2.31e-05 | 193 | 131 | 6 | 484c2e0daedc6cb0d50d164add8c1658123a60f9 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 194 | 131 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.38e-05 | 194 | 131 | 6 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.38e-05 | 194 | 131 | 6 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.38e-05 | 194 | 131 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 194 | 131 | 6 | d602a0cdb69cd5a3e9ef61ddbab8d920557dd73e | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.38e-05 | 194 | 131 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-05 | 194 | 131 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.45e-05 | 195 | 131 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.45e-05 | 195 | 131 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.45e-05 | 195 | 131 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.45e-05 | 195 | 131 | 6 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.45e-05 | 195 | 131 | 6 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.52e-05 | 196 | 131 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.52e-05 | 196 | 131 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.52e-05 | 196 | 131 | 6 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.52e-05 | 196 | 131 | 6 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.52e-05 | 196 | 131 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.59e-05 | 197 | 131 | 6 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.59e-05 | 197 | 131 | 6 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.59e-05 | 197 | 131 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 197 | 131 | 6 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | URO-Myeloid-cDC2|URO / Disease, Lineage and Cell Type | 2.59e-05 | 197 | 131 | 6 | 7fee14356d7fba68a0515c8b9284568d14124b0a | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 2.59e-05 | 197 | 131 | 6 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.59e-05 | 197 | 131 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Epithelial_cells-Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.67e-05 | 198 | 131 | 6 | 52e9d41a1726bc1140df6baec9f17a534448ac8b | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.67e-05 | 198 | 131 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.67e-05 | 198 | 131 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | COVID-19_Severe-cDC|COVID-19_Severe / Disease condition and Cell class | 2.67e-05 | 198 | 131 | 6 | e0b16627a347e245bedd71b1e0ccdb46c1c1bd6d | |
| ToppCell | COVID-19_Severe-cDC-|COVID-19_Severe / Disease condition and Cell class | 2.67e-05 | 198 | 131 | 6 | 3914140238598914674c08c5ad83354b9485825f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-05 | 198 | 131 | 6 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Epithelial_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.67e-05 | 198 | 131 | 6 | eeec789d226171f30799577cc37c07bdced2e3cb | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-05 | 199 | 131 | 6 | f544229f471b4717166dd4b588399afe45cc31b5 | |
| ToppCell | control-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.74e-05 | 199 | 131 | 6 | 31825ba336603fe940dea6022e18ec25af110f4c | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 2.74e-05 | 199 | 131 | 6 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.74e-05 | 199 | 131 | 6 | 126a0ebd40e55c0dfb5e7c7dd8fdd733da6aa323 | |
| ToppCell | mild-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-05 | 200 | 131 | 6 | 86f585bf9066b179bbcbc703bf43f15da4a07284 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.82e-05 | 200 | 131 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-cDC|Influenza_Severe / Disease, condition lineage and cell class | 2.82e-05 | 200 | 131 | 6 | b8415a68ad6f4fea562236a1b0da0dc376d874fb | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.82e-05 | 200 | 131 | 6 | a0eb6e9e21930539b8939082c4097f6dfe8efa9b | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 2.82e-05 | 200 | 131 | 6 | a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888 | |
| ToppCell | Sepsis-URO-Myeloid-cDC2|URO / Disease, condition lineage and cell class | 2.82e-05 | 200 | 131 | 6 | 4f696dc68a8ceec9a6e6293c6f6f878b321b0b6d | |
| ToppCell | Sepsis-Int-URO-Myeloid-cDC2|Int-URO / Disease, condition lineage and cell class | 2.82e-05 | 200 | 131 | 6 | dd8ac355b3b0394fda005789f9f2ff6560a02dac | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-05 | 140 | 131 | 5 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 9.26e-05 | 154 | 131 | 5 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 9.84e-05 | 156 | 131 | 5 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.01e-04 | 157 | 131 | 5 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 158 | 131 | 5 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| Drug | NAD | 1.87e-08 | 80 | 130 | 8 | ctd:D009243 | |
| Drug | glyceraldehyde-3-phosphate | 2.70e-08 | 159 | 130 | 10 | CID000000729 | |
| Drug | m189 | 7.85e-08 | 178 | 130 | 10 | CID000022230 | |
| Drug | Xanthine | 8.82e-07 | 57 | 130 | 6 | ctd:D019820 | |
| Drug | Tetracycline | TRPM6 HSPD1 PDE6A SLCO1B3 STAM RTCA PKLR PYGL ALDH1A1 HADH HSD17B4 PC GGA1 DHX29 CTSL ABCG5 | 1.38e-06 | 668 | 130 | 16 | ctd:D013752 |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.11e-06 | 198 | 130 | 9 | 5742_DN | |
| Drug | Erythromycin Estolate | 3.09e-06 | 109 | 130 | 7 | ctd:D004918 | |
| Drug | oxalate | 3.57e-06 | 158 | 130 | 8 | CID000000971 | |
| Drug | papaverine | 7.92e-06 | 176 | 130 | 8 | CID000004680 | |
| Drug | amorphin | 9.98e-06 | 8 | 130 | 3 | CID000122792 | |
| Drug | NSC7524 | 1.01e-05 | 182 | 130 | 8 | CID000005657 | |
| Drug | valdecoxib | TCP1 CHDH HSPH1 FASTKD2 CMYA5 LGALS8 HSD17B13 PKLR LRP5 PYGL ALDH1A1 PC CTSL ABCG5 RAD23B | 1.24e-05 | 705 | 130 | 15 | ctd:C406224 |
| Drug | Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; HL60; HG-U133A | 1.80e-05 | 197 | 130 | 8 | 1410_DN | |
| Drug | N-nitrosomorpholine | 2.51e-05 | 338 | 130 | 10 | ctd:C002741 | |
| Drug | Amiodarone | TRPM6 HSPD1 PDE6A MYO1D CHAF1A DHX57 CMYA5 XRCC5 DNAH7 SPPL2A ASAH1 RTCA SCN5A PKLR LRP5 PYGL ALDH1A1 ALDH2 HSD17B4 PC ABCG5 ZC3HAV1 | 2.88e-05 | 1469 | 130 | 22 | ctd:D000638 |
| Drug | betaine aldehyde | 3.22e-05 | 32 | 130 | 4 | CID000000249 | |
| Drug | 2-Phosphoglycolic Acid | 3.24e-05 | 2 | 130 | 2 | DB02726 | |
| Drug | 4-dimethylaminocinnamaldehyde | 3.24e-05 | 2 | 130 | 2 | ctd:C018523 | |
| Drug | N-methyltaurine | 3.24e-05 | 2 | 130 | 2 | CID000007882 | |
| Drug | NPCMD | 3.24e-05 | 2 | 130 | 2 | CID000126341 | |
| Drug | BW A440C | 3.24e-05 | 2 | 130 | 2 | CID003086296 | |
| Drug | 3-(fluoromethyl)phosphoenolpyruvate | 3.24e-05 | 2 | 130 | 2 | CID006443899 | |
| Drug | SENP | 3.24e-05 | 2 | 130 | 2 | CID003082911 | |
| Drug | 8-BDB-TATP | 3.24e-05 | 2 | 130 | 2 | CID003082732 | |
| Drug | AC1Q6SAF | 3.24e-05 | 2 | 130 | 2 | CID000194977 | |
| Drug | Adenosine 5'-monophosphate 1-oxide | 3.24e-05 | 2 | 130 | 2 | CID000492161 | |
| Drug | coenzyme 1 | EPRS1 CHDH XDH RYR3 ALDH1L2 PKLR PKM ALDH1A1 HADH ALDH2 HSD11B1 HSD17B4 PC | 3.79e-05 | 596 | 130 | 13 | CID000000925 |
| Drug | phenylurethane | 3.85e-05 | 12 | 130 | 3 | CID000007591 | |
| Drug | Methamphetamine | HSPD1 SLK DRD2 PDE8A NUP210L MYT1 UBR4 XDH LLPH USH1C TRIP10 PDIA4 FANK1 SCN5A PKM MACF1 MTARC2 ALDH2 PUM1 REM2 GOLGB1 | 4.43e-05 | 1401 | 130 | 21 | ctd:D008694 |
| Drug | NADP(H | GPI DRD2 XDH PBRM1 TXNRD3 PYGL ALDH1A1 HADH ALDH2 HSD11B1 HSD17B4 PC | 5.06e-05 | 527 | 130 | 12 | CID000000930 |
| Drug | nimesulide | HSPD1 EPRS1 MYO1D TCP1 HSPH1 SLCO1B3 CEACAM1 PDIA4 HSD17B13 PKLR LRP5 PYGL TOMM40 ALCAM ALDH1A1 HSD17B4 PC CTSL CAP1 | 5.28e-05 | 1202 | 130 | 19 | ctd:C012655 |
| Drug | Glucose | HSPD1 CACNA1D RASA3 SLC2A7 XDH XRCC5 OPA1 CEACAM1 LGALS8 PDIA4 PBRM1 PIM1 SLC25A1 GNA13 PKLR PKM PYGL HADH KLHL8 PC CTSL | 5.38e-05 | 1420 | 130 | 21 | ctd:D005947 |
| Drug | Ethionine | 5.52e-05 | 298 | 130 | 9 | ctd:D005001 | |
| Drug | Dronabinol | HSPD1 GPI DRD2 MAP1B HSPH1 UBR4 XRCC5 DNAH7 CASKIN1 PKM ALCAM HSD11B1 SPEN REM2 GOLGB1 CAP1 | 5.96e-05 | 905 | 130 | 16 | ctd:D013759 |
| Drug | Pyruvic acid | 6.32e-05 | 14 | 130 | 3 | DB00119 | |
| Drug | Glafenine | EPRS1 APPBP2 PDE8A MYO1D SLCO1B3 GPR108 CEMIP2 CEACAM1 LGALS8 PDIA4 PYGL MTARC2 TOMM40 ALDH1A1 HADH ALDH2 HSD17B4 ABCG5 RAD21 KPNA2 | 6.39e-05 | 1327 | 130 | 20 | ctd:D005897 |
| Drug | 4-hydroxycyclophosphamide | 6.44e-05 | 38 | 130 | 4 | CID000099735 | |
| Drug | hydroxyl radicals | CYLD PDE6A PDE8A PDE6B CHDH XDH PPP3CC ASAH1 ALDH1L2 SLC25A1 PLCL2 PKLR PKM ALDH1A1 HADH ALDH2 HSD11B1 HSD17B4 PC USP15 | 7.38e-05 | 1341 | 130 | 20 | CID000000961 |
| Drug | Nicotinamide-Adenine-Dinucleotide | 7.91e-05 | 40 | 130 | 4 | DB01907 | |
| Drug | glycerol | HSPD1 GPI EPRS1 NCOA6 XDH SUCLG2 PBRM1 PKLR PKM LRP5 PYGL ALDH1A1 ALDH2 HSD17B4 PC | 7.96e-05 | 829 | 130 | 15 | CID000000753 |
| Drug | dicyclohexyl phthalate | CYLD EPRS1 MAP1B INPP5D LRRK2 XDH PDIA4 PBRM1 ASAH1 TXNRD3 PKM ALDH1A1 HSD17B4 PC ABCG5 | 8.74e-05 | 836 | 130 | 15 | ctd:C036042 |
| Drug | quinocetone | 9.17e-05 | 248 | 130 | 8 | ctd:C502851 | |
| Drug | nitrosobenzylmethylamine | HSPD1 DRD2 TCP1 INPP5D PYGL MTARC2 ALCAM ALDH1A1 HADH ALDH2 USP15 KPNA2 | 9.18e-05 | 561 | 130 | 12 | ctd:C014707 |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 9.19e-05 | 184 | 130 | 7 | 1051_UP | |
| Drug | caffeine | GPI CACNA1D DRD2 PDE6A PDE8A PDE6B XDH MSTN RYR3 SEC61A2 PYGL CACNA2D3 | 9.33e-05 | 562 | 130 | 12 | CID000002519 |
| Drug | 6-o-phosphonohexose | 9.51e-05 | 185 | 130 | 7 | CID000099058 | |
| Drug | diethoxyfluorescein | 9.67e-05 | 3 | 130 | 2 | CID000161373 | |
| Drug | NSC 18508 | 9.67e-05 | 3 | 130 | 2 | CID000189182 | |
| Drug | 1-thio-alpha-tocopherol | 9.67e-05 | 3 | 130 | 2 | CID000131683 | |
| Drug | 2-cyanopyridine | 9.67e-05 | 3 | 130 | 2 | CID000007522 | |
| Drug | Benzaldehydes | 9.67e-05 | 3 | 130 | 2 | ctd:D001547 | |
| Drug | 2 PEB | 9.67e-05 | 3 | 130 | 2 | CID000447809 | |
| Drug | NSC406942 | HSPD1 TCP1 CHDH HSPH1 RYR3 PDIA4 PBRM1 PKLR LRP5 PYGL HADH RAD23B | 9.81e-05 | 565 | 130 | 12 | CID000001115 |
| Drug | Benzbromarone | 1.09e-04 | 326 | 130 | 9 | ctd:D001553 | |
| Drug | Streptozocin | HSPD1 GATM XDH SLC25A1 PKLR PKM LRP5 PYGL TOMM40 ALDH1A1 ALDH2 HSD17B4 PC ABCG5 | 1.10e-04 | 756 | 130 | 14 | ctd:D013311 |
| Drug | F0447-0125; Up 200; 10uM; PC3; HT_HG-U133A | 1.12e-04 | 190 | 130 | 7 | 6429_UP | |
| Drug | beta-NADP | GPI XDH HSD17B13 TXNRD3 PKLR PKM PYGL ALDH1A1 ALDH2 HSD11B1 PC | 1.19e-04 | 490 | 130 | 11 | CID000000929 |
| Drug | 4,4'-dithiodipyridine | 1.26e-04 | 45 | 130 | 4 | CID000075846 | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.28e-04 | 194 | 130 | 7 | 3885_UP | |
| Drug | arabinopyranose | 1.30e-04 | 261 | 130 | 8 | CID000000229 | |
| Drug | Dichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 3366_UP | |
| Drug | H-7 dihydrochloride; Up 200; 100uM; PC3; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 5941_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 195 | 130 | 7 | 7469_UP | |
| Drug | C11102 | 1.35e-04 | 86 | 130 | 5 | CID000443069 | |
| Drug | Albendazole | 1.38e-04 | 46 | 130 | 4 | ctd:D015766 | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 130 | 7 | 5360_UP | |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 5738_DN | |
| Drug | oxaloacetate | 1.45e-04 | 198 | 130 | 7 | CID000000970 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 130 | 7 | 2346_DN | |
| Drug | succinate | 1.47e-04 | 339 | 130 | 9 | CID000001110 | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 1.50e-04 | 199 | 130 | 7 | 6478_UP | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.54e-04 | 200 | 130 | 7 | 2912_UP | |
| Drug | reduced diphosphopyridine nucleotide | 1.57e-04 | 342 | 130 | 9 | CID000000928 | |
| Drug | alanine | 1.60e-04 | 269 | 130 | 8 | CID000000602 | |
| Drug | Ro 18-5364 | 1.93e-04 | 4 | 130 | 2 | CID000127803 | |
| Drug | 8-BDB-TADP | 1.93e-04 | 4 | 130 | 2 | CID000130791 | |
| Drug | AC1L9CUH | 1.93e-04 | 4 | 130 | 2 | CID000442448 | |
| Drug | AC1L9CUK | 1.93e-04 | 4 | 130 | 2 | CID000442449 | |
| Drug | aminophosphate | 1.93e-04 | 4 | 130 | 2 | CID000440067 | |
| Drug | 3-fluorooxaloacetate | 1.93e-04 | 4 | 130 | 2 | CID000193291 | |
| Drug | 2,3 pg | 1.93e-04 | 4 | 130 | 2 | CID003081496 | |
| Drug | 3-methyl-2-nitrophenol | 1.93e-04 | 4 | 130 | 2 | CID000021026 | |
| Drug | levodopa methyl ester | 1.93e-04 | 4 | 130 | 2 | ctd:C035420 | |
| Drug | 6-nitrotryptophan | 1.93e-04 | 20 | 130 | 3 | CID000600156 | |
| Drug | entacapone | 1.93e-04 | 20 | 130 | 3 | ctd:C071192 | |
| Drug | 2-phosphoglycerate | 2.05e-04 | 94 | 130 | 5 | CID000000059 | |
| Drug | phosphoenolpyruvate | 2.08e-04 | 210 | 130 | 7 | CID000001005 | |
| Drug | Glyoxal | 2.24e-04 | 21 | 130 | 3 | ctd:D006037 | |
| Drug | neotrehalose | 2.34e-04 | 214 | 130 | 7 | CID000001143 | |
| Drug | 6-Bromomannitol | 2.59e-04 | 22 | 130 | 3 | CID000027283 | |
| Drug | indioside D | 2.59e-04 | 22 | 130 | 3 | ctd:C428264 | |
| Disease | combined oxidative phosphorylation deficiency (implicated_via_orthology) | 5.76e-05 | 3 | 130 | 2 | DOID:0060286 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in small HDL percentage | 7.66e-05 | 51 | 130 | 4 | EFO_0022285 | |
| Disease | Malignant neoplasm of breast | GPI NCOA6 TCP1 DYNC2H1 UBR4 XDH BCL11A ZNF25 PBRM1 PIM1 MACF1 HSD11B1 SPEN GGA1 GOLGB1 | 8.04e-05 | 1074 | 130 | 15 | C0006142 |
| Disease | congenital nonspherocytic hemolytic anemia (is_implicated_in) | 1.91e-04 | 5 | 130 | 2 | DOID:2861 (is_implicated_in) | |
| Disease | Thymoma | 1.91e-04 | 5 | 130 | 2 | C0040100 | |
| Disease | hypertension (is_implicated_in) | 2.03e-04 | 121 | 130 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | Autosomal Dominant Parkinsonism | 2.53e-04 | 28 | 130 | 3 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 2.53e-04 | 28 | 130 | 3 | C0752097 | |
| Disease | Parkinsonism, Experimental | 2.53e-04 | 28 | 130 | 3 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 2.53e-04 | 28 | 130 | 3 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 2.53e-04 | 28 | 130 | 3 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 2.53e-04 | 28 | 130 | 3 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 2.53e-04 | 28 | 130 | 3 | C1868675 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.64e-04 | 128 | 130 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.64e-04 | 128 | 130 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.64e-04 | 128 | 130 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.64e-04 | 128 | 130 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.64e-04 | 128 | 130 | 5 | C0007134 | |
| Disease | interleukin 17 receptor B measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0008176 | |
| Disease | Sick Sinus Syndrome | 2.86e-04 | 6 | 130 | 2 | C0037052 | |
| Disease | Parkinsonism, Juvenile | 3.11e-04 | 30 | 130 | 3 | C0752105 | |
| Disease | Parkinsonian Disorders | 3.11e-04 | 30 | 130 | 3 | C0242422 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.13e-04 | 206 | 130 | 6 | C0152013 | |
| Disease | obesity (implicated_via_orthology) | 3.93e-04 | 215 | 130 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Thymic Carcinoma | 3.99e-04 | 7 | 130 | 2 | C0205969 | |
| Disease | cortical thickness | PDE8A NUP210L CHAF1A PM20D1 USH1C VPS13D GNA13 MACF1 ALCAM KLHL8 USP15 CACNA2D3 EPHA7 RAD23B | 4.08e-04 | 1113 | 130 | 14 | EFO_0004840 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.13e-04 | 148 | 130 | 5 | C0279702 | |
| Disease | pyoderma gangrenosum | 6.80e-04 | 9 | 130 | 2 | EFO_0006835 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 8.47e-04 | 10 | 130 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | neuroimaging measurement | SCFD2 HSPD1 PDE8A MAP1B CHAF1A PM20D1 STAM GNA13 MACF1 TOMM40 ALCAM PC RAD23B | 9.01e-04 | 1069 | 130 | 13 | EFO_0004346 |
| Disease | schizophrenia (is_marker_for) | 9.70e-04 | 44 | 130 | 3 | DOID:5419 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 9.85e-04 | 171 | 130 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.03e-03 | 11 | 130 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement | 1.06e-03 | 260 | 130 | 6 | EFO_0008317 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 1.31e-03 | 107 | 130 | 4 | DOID:6000 (biomarker_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 1.33e-03 | 49 | 130 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Condition, Preneoplastic | 1.45e-03 | 110 | 130 | 4 | C0282313 | |
| Disease | Precancerous Conditions | 1.45e-03 | 110 | 130 | 4 | C0032927 | |
| Disease | cirrhosis of liver | 1.46e-03 | 13 | 130 | 2 | EFO_0001422 | |
| Disease | smoking status measurement, ulcerative colitis | 1.46e-03 | 13 | 130 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | testosterone measurement | SCFD2 TRPM6 TET2 CACNA1D NCOA6 PDE8A IQSEC2 XDH SLCO1B3 HSD17B13 LRP5 MACF1 KLHL8 KPNA2 | 1.51e-03 | 1275 | 130 | 14 | EFO_0004908 |
| Disease | African Burkitt's lymphoma | 1.95e-03 | 15 | 130 | 2 | C0343640 | |
| Disease | Burkitt Leukemia | 1.95e-03 | 15 | 130 | 2 | C4721444 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.95e-03 | 56 | 130 | 3 | EFO_0022279 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.06e-03 | 57 | 130 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Schizoaffective disorder-bipolar type | 2.22e-03 | 16 | 130 | 2 | EFO_0009965 | |
| Disease | cathepsin L1 measurement | 2.22e-03 | 16 | 130 | 2 | EFO_0010619 | |
| Disease | reticulocyte count | EPRS1 NCOA6 MYO1D DNAH10 INPP5D BCL11A GREB1L RASSF5 GNA13 PKLR LRP5 ZC3HAV1 | 2.29e-03 | 1045 | 130 | 12 | EFO_0007986 |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.45e-03 | 307 | 130 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | cortical surface area measurement | SCFD2 TRPM6 TET2 PDE8A CHAF1A MYT1 DNAH7 RALBP1 MACF1 SEMA6A ALCAM PC EPHA7 RAD23B | 2.47e-03 | 1345 | 130 | 14 | EFO_0010736 |
| Disease | Post-Traumatic Osteoporosis | 2.50e-03 | 61 | 130 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 2.50e-03 | 61 | 130 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 2.50e-03 | 61 | 130 | 3 | C0001787 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.51e-03 | 17 | 130 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Disorder of eye | 2.53e-03 | 212 | 130 | 5 | C0015397 | |
| Disease | Osteoporosis | 2.74e-03 | 63 | 130 | 3 | C0029456 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.74e-03 | 63 | 130 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.74e-03 | 63 | 130 | 3 | EFO_0022239 | |
| Disease | primary biliary cirrhosis | 2.89e-03 | 133 | 130 | 4 | EFO_1001486 | |
| Disease | myeloid white cell count | SCFD2 TET2 DNAH10 RASA3 RASSF5 SPPL2A SLC25A1 RTCA PRORP GGA1 ZC3HAV1 | 2.94e-03 | 937 | 130 | 11 | EFO_0007988 |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0007709 | |
| Disease | triglyceride measurement, body mass index | 3.14e-03 | 19 | 130 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | total lipids in small VLDL | 3.26e-03 | 67 | 130 | 3 | EFO_0022148 | |
| Disease | Alcohol abuse | 3.26e-03 | 67 | 130 | 3 | C0085762 | |
| Disease | hypertension (biomarker_via_orthology) | 3.39e-03 | 227 | 130 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Animal Mammary Neoplasms | 3.66e-03 | 142 | 130 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 3.66e-03 | 142 | 130 | 4 | C1257925 | |
| Disease | triglyceride measurement, body fat percentage | 3.83e-03 | 21 | 130 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 3.83e-03 | 21 | 130 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | disease of metabolism (implicated_via_orthology) | 3.83e-03 | 21 | 130 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | corneal resistance factor | 3.93e-03 | 451 | 130 | 7 | EFO_0010067 | |
| Disease | Colorectal Carcinoma | 3.99e-03 | 702 | 130 | 9 | C0009402 | |
| Disease | obesity (biomarker_via_orthology) | 4.13e-03 | 147 | 130 | 4 | DOID:9970 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVKGDEIMAINGKIV | 496 | Q9Y6N9 | |
| FPEGIKAMVEAVQLI | 191 | Q3SY69 | |
| DVKVQVMGKVPTISI | 396 | Q01518 | |
| IAKEEIFGPVQQIMK | 396 | P00352 | |
| EAMKEITAGLPVKVV | 231 | Q92624 | |
| TFVPSGKIMQVVDEK | 86 | Q13510 | |
| VNMVEKGIIDPTKVV | 511 | P10809 | |
| ILFKGKVPMVVLQDI | 231 | Q13111 | |
| EFRPEMLQGKKVIVT | 26 | P28845 | |
| LPVNVKIGKMLIFGA | 1076 | Q7Z478 | |
| LIDGILTNKKMIFVP | 246 | Q7Z5P4 | |
| IMIAEKAADIIKGQP | 561 | Q8NE62 | |
| EKNFVVVMVTKPKAV | 66 | P54727 | |
| ELFGNVVLKQVMKPL | 366 | Q15311 | |
| SVEQPIVLKEGFMIK | 571 | Q14644 | |
| VIQGLLKKFMVVDNP | 301 | Q8WWW0 | |
| AFIKIKMAFRPGVVD | 81 | O60216 | |
| VQGPLEMKKQFVEFT | 806 | Q5JSJ4 | |
| MKEALKGAIQIPTVT | 51 | Q6GTS8 | |
| PLVALFKGKQISVQM | 911 | Q7Z5J8 | |
| EPMKLVLKAGSAVNI | 96 | Q8WXD9 | |
| VPVSKILGKCVVMFV | 1026 | Q86U86 | |
| IDPVILFQKMGVGKL | 406 | P46821 | |
| EVPIQKMFEKLGITT | 376 | P50440 | |
| IIPAILMGVSKVAKA | 116 | Q6PXP3 | |
| VIMVLKDKFQVAVNG | 106 | O00214 | |
| FFNPVPVMKLVEVIK | 171 | Q16836 | |
| VQAVERMIVGKKPVL | 951 | Q5JU85 | |
| VDPKTGEKIMQQVLI | 1091 | Q5HYC2 | |
| MKIGTPVKVRFQEAE | 696 | Q92598 | |
| PDLMGLKAVNVAKVV | 586 | O75197 | |
| MKDVQEIATVVVPKP | 41 | Q9BRT6 | |
| EMKKASNPVEVGIQV | 91 | Q9H165 | |
| LPVDFLMGVVAKEQI | 261 | Q9P2G9 | |
| LSMPIVNKKEEIVGV | 386 | P16499 | |
| VVAVIMAVNKLNGPF | 186 | P35913 | |
| MPIVNKKEEIVGVAT | 386 | P35913 | |
| KKVAVADVQFGPMRF | 61 | O60658 | |
| LFNPNKTVVKMFVVI | 961 | Q32MH5 | |
| KVVPTVYMKVDGEVL | 281 | Q9Y282 | |
| GRIPQVFLKQIEKTM | 411 | A0PJZ3 | |
| FVLSAVVPDKMQKAI | 261 | Q6P1Q9 | |
| PADVIQARGMKKQII | 336 | Q9Y2G8 | |
| KDMKNVVGVVVTLTP | 51 | P62502 | |
| IMAQILTVKVEGCPK | 1606 | Q5S007 | |
| IPAEKVFLAQKMMIG | 301 | P14618 | |
| GIEIPAEKVFLAQKM | 341 | P30613 | |
| RNIVFQSAVPKVMKV | 556 | Q9UJY5 | |
| INFKIVEFNPMVLKG | 106 | Q9H1C3 | |
| ILVDGKDVMPEVNKV | 111 | P06744 | |
| FEIKNVPFKMVDVGG | 211 | Q14344 | |
| PKFEQIVGILDKMIR | 881 | Q15375 | |
| GQRDFIIKPKIMVSE | 1746 | Q9C091 | |
| TVEIFPIFKAMQKGL | 1556 | Q9UPN3 | |
| QKMIDVAEPGQRKIV | 1126 | Q14671 | |
| IGMVVKTGVVPQLVK | 286 | P52292 | |
| LKAVPAQEVKMVVPE | 1441 | Q14686 | |
| RIQQIIEGKLFPMKA | 481 | O60313 | |
| MKSLEGEVVPFKNKV | 1476 | Q8NCM8 | |
| PIGKKAVVFVDDLNM | 2131 | Q8TD57 | |
| KSPVVAAVGIQMKLE | 811 | Q8IZS8 | |
| MPFNVAEGKEVLLLV | 41 | P13688 | |
| GAVRMQPKSAELKFV | 1241 | Q6P158 | |
| MEVVLGKLDPQKAFF | 696 | P51659 | |
| VETVGNVAMQKKAPI | 3311 | Q8N3K9 | |
| KEKVNEKPLGMAFVT | 351 | Q5T3F8 | |
| PAGVKLVMEAICILK | 2701 | Q8WXX0 | |
| PGSFQKKVEAVMAEL | 161 | Q9H222 | |
| VKVKETPQFLHMGEI | 461 | Q9UHN6 | |
| NKMPFKLQEGEVRII | 936 | Q9Y5Q5 | |
| LLIGSVEVKKVMACP | 256 | Q969Z3 | |
| RIGDVIQKLAPFLKM | 181 | Q7Z6J4 | |
| KIAKIFEIQTMPNGK | 336 | P14416 | |
| QIFMEKNEKVGVPTI | 716 | Q9NQC7 | |
| MIGIFKNIISKPNEK | 511 | A5D8W1 | |
| LEQMVKIKQPVIFVG | 2441 | Q8IVF4 | |
| GQVAKEIENKMPKVF | 4201 | Q8IVF4 | |
| KVIDMVKAGLGVNIV | 546 | Q9BZW2 | |
| EGAVVIIFKKEMDPV | 181 | Q13740 | |
| GVFTVEMVLKVIAFK | 1246 | Q01668 | |
| KMVQGRVTEVKFPLE | 276 | Q5VU65 | |
| QDPKIQKEIMRVIGT | 611 | Q2NL67 | |
| VPMEVVLLKKVSSGF | 86 | P11309 | |
| KVDVPNKFGFTALMV | 136 | Q8TC84 | |
| KFVELPGAEMGKVTV | 186 | P07814 | |
| EVVEVGQKLINKPMV | 576 | Q9H2G2 | |
| MGIKFLEVIKPFCAV | 1 | Q9H9S3 | |
| ILKVGFPIKTVQMEI | 466 | B5MCY1 | |
| QVVMKCIGKDAPIAL | 311 | Q9NYY8 | |
| KEQIIYGKIPAMVVD | 356 | O14793 | |
| SDKEKKVFGIVIPMQ | 361 | Q9NPR9 | |
| TMELQGIVPEVLKKI | 986 | Q9UPR0 | |
| GVSQVAVVLLMFPKE | 6 | A8MTI9 | |
| IKQGVKLVVMDPFTD | 706 | Q14524 | |
| FEVKAESLGIPQKMQ | 301 | Q92835 | |
| MKLGVQVVITDPEKL | 246 | P17987 | |
| PVKVVVGKTFDSIVM | 526 | P13667 | |
| MVKDLVASLKPGTQV | 641 | Q8WU76 | |
| VVIDGLNVAKMFPKV | 406 | O15091 | |
| TVGPKMLVNFVVDKN | 76 | Q8NH51 | |
| VFAPVIQAGMEALKA | 556 | O94855 | |
| ELISKFEKPNQGMVV | 81 | O14796 | |
| QEKALMKAVATVGPI | 231 | P07711 | |
| EIFGPVMQILKFKTI | 416 | P05091 | |
| VVPIIAKCLEGMKVA | 241 | Q15642 | |
| PFVGEKVTEMLVNVL | 351 | P48454 | |
| PKEGVKVNKVMVAEA | 131 | Q96I99 | |
| VIKPEVKQSRGMVFG | 1936 | Q9BX84 | |
| GPVVKVVFDRLKGMA | 541 | Q96T58 | |
| VLGTEKSQIAFPKMV | 2076 | Q15413 | |
| MGKVVFPRVAQVCKN | 246 | Q9H2E6 | |
| AFVAGVLPFKVAKDM | 196 | O00442 | |
| KIVQPELKALAMGFQ | 561 | Q9NPD5 | |
| TFVVLVLMKKGQPAL | 451 | Q8TCT8 | |
| AVVVVCPMETIKVKF | 136 | P53007 | |
| EPIARKVVEQGMFVK | 111 | Q9Y4E8 | |
| MIKNLKEQGVTFPAI | 131 | Q92783 | |
| KLVVGNTEIGIEMKF | 256 | P47989 | |
| AAPAQKDGIFKVMLV | 106 | Q8IYK8 | |
| KELFPIQMEGVKLTV | 91 | O96008 | |
| MNKFQGPVTLKDVIV | 1 | P17030 | |
| FPAQMEGVKLVVNKV | 41 | Q969M1 | |
| AILGKKVMVLDFVVP | 176 | Q86VQ6 | |
| KNVVMFVAQVLVGKF | 836 | Q7Z2W4 | |
| GEVEKMQILVERFKP | 4626 | Q5T4S7 | |
| QKQVKVEMSGPVTVL | 1051 | Q6N021 | |
| VNNDPMVGSKLKVIF | 631 | P06737 | |
| VVKQEGKLVMIERTP | 1441 | Q6ZQQ6 | |
| PIKKVMVANRGEIAI | 36 | P11498 | |
| GIESPFEQAKKVITM | 26 | P13010 | |
| SIMKIEGKFVNPVQV | 1521 | Q5THJ4 | |
| IAPIKMKVFLEDTGQ | 606 | Q14789 | |
| ADAMKVIGFKPEEIQ | 251 | O94832 | |
| DAQVFGKRMLAPKIQ | 591 | Q01538 | |
| PVDMLGVVLAKKCQT | 2846 | P20929 | |
| KELIPLVVFMTVAAG | 11 | Q9C002 |